Researchers

no image

Faculty	Department of Medicine
Researchmap	https://researchmap.jp/muratad221217

Apr. 2025 - Today , Kindai University Faculty of Medicine, Department of Medical Oncology
Apr. 2024 - Mar. 2025 , Kurume University School of Medicine Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine
Oct. 2022 - Mar. 2024 , Saga-Ken Medical Centre Koseikan Division of Respiratory Medicine
Apr. 2021 - Sep. 2022 , Kurume University School of Medicine Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine
Apr. 2019 - Mar. 2021 , National Hospital Organization, Kure Medical Center and Chugoku Cancer Center junior resident

免疫療法, 肺癌

Comparative analysis of first-line treatment in NSCLC including unresectable stage III (IIIB/IIIC) and stage IV with low PD-L1 expression: Clinical trial eligible versus ineligible patients.
Tae Hata; Tadaaki Yamada; Yasuhiro Goto; Akihiko Amano; Yoshiki Negi; Satoshi Watanabe; Naoki Furuya; Tomohiro Oba; Tatsuki Ikoma; Akira Nakao; Keiko Tanimura; Hirokazu Taniguchi; Akihiro Yoshimura; Tomoya Fukui; Daiki Murata; Kyoichi Kaira; Shinsuke Shiotsu; Makoto Hibino; Asuka Okada; Yusuke Chihara; Hayato Kawachi; Takashi Kijima; Koichi Takayama
Lung cancer (Amsterdam, Netherlands) 200 , 108104-108104, Feb. 2025
The Impacts of Active and Inactive Ghrelin on Cachexia and Immune Checkpoint Inhibitor Monotherapy in Patients with Non-small Cell Lung Cancer
Daiki Murata; Koichi Azuma; Yuuya Nishii; Kenta Murotani; Goushi Matama; Akihiko Kawahara; Takaaki Tokito; Tetsuro Sasada; Tomoaki Hoshino
Chemotherapy 22, Jan. 2025
Regimen Selection for Chemoimmunotherapy in Nonsquamous Non-Small Cell Lung Cancer with Low PD-L1 Expression: A Multicenter Retrospective Cohort Study.
Tae Hata; Tadaaki Yamada; Yasuhiro Goto; Akihiko Amano; Yoshiki Negi; Satoshi Watanabe; Naoki Furuya; Tomohiro Oba; Tatsuki Ikoma; Akira Nakao; Keiko Tanimura; Hirokazu Taniguchi; Akihiro Yoshimura; Tomoya Fukui; Daiki Murata; Kyoichi Kaira; Shinsuke Shiotsu; Makoto Hibino; Asuka Okada; Yusuke Chihara; Hayato Kawachi; Takashi Kijima; Koichi Takayama
Clinical lung cancer 4, Jan. 2025

腫瘍内科32巻4号 , 村田大樹; 東公一 , 免疫療法の光と影抗CTLA-4抗体と抗PD-1抗体あるいは抗PD-L1抗体の併用の安全性と有効性のバランスは? , 免疫療法の光と影抗CTLA-4抗体と抗PD-1抗体あるいは抗PD-L1抗体の併用の安全性と有効性のバランスは? , 科学評論社 , Oct. 2023
日本臨牀80巻増刊最新臨床肺癌学-診断・治療の最新動向- , 村田大樹; 東公一 , V. 治療集学的治療脳転移の管理 , V. 治療集学的治療脳転移の管理 , 日本臨牀 , Dec. 2022

悪液質を有する非小細胞肺癌患者において活性型および非活性型Ghrelinが免疫チェックポイント阻害剤単剤治療に及ぼす影響に関する検討 , 村田大樹; 東公一; 西井裕哉; 時任高章; 星野友昭 , 肺癌 , 64 , 3 , 213 , 214 , Jun. 2024
腫瘍免疫療法・予後予測因子 Multiplex assayを用いた非小細胞肺癌に対する免疫チェックポイント阻害剤単剤治療における予後予測因子の探索的検討 , 村田大樹; 東公一; 西井裕哉; 時任高章; 星野友昭 , 日本呼吸器学会誌 , 13 , 増刊 , 194 , 194 , Mar. 2024
肺癌合併症間質性肺異常陰影が非小細胞肺癌患者に対する免疫チェックポイント阻害薬単剤治療に及ぼす影響に関する検討 , 村田大樹; 東公一; 西井裕哉; 時任高章; 星野友昭 , 日本呼吸器学会誌 , 13 , 増刊 , 221 , 221 , Mar. 2024